UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection

Cochrane database of systematic reviews, 2012-03 (3), p.CD009756

2012

Volltextzugriff (PDF)

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

Cochrane database of systematic reviews, 2016-12, Vol.12 (12), p.CD004246

2016

Volltextzugriff (PDF)

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

HIV medicine, 2023-06, Vol.24 (6), p.653-663

2023

Volltextzugriff (PDF)

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Journal of medical virology, 2018-03, Vol.90 (3), p.518-525

2018

Volltextzugriff (PDF)

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

British journal of clinical pharmacology, 2021-03, Vol.87 (3), p.1547-1553

2021

Volltextzugriff (PDF)

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

Cochrane database of systematic reviews, 2010-03 (3), p.CD008440

2010

Volltextzugriff (PDF)

Interventions to improve adherence to antiretroviral therapy in children with HIV infection

Cochrane database of systematic reviews, 2011-12 (12), p.CD009513

2011

Volltextzugriff (PDF)

InterPrEP: internet‐based pre‐exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London – analysis of pharmacokinetics, safety and outcomes

HIV medicine, 2018-01, Vol.19 (1), p.1-6

2018

Volltextzugriff (PDF)

Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old

Cochrane database of systematic reviews, 2013-10, Vol.10 (10), p.CD010309-CD010309

2013

Volltextzugriff (PDF)

Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

HIV medicine, 2017-04, Vol.18 (4), p.256-266

2017

Volltextzugriff (PDF)

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection

Cochrane database of systematic reviews, 2014-07, Vol.2014 (7), p.CD008439-CD008439

2014

Volltextzugriff (PDF)

The Response to Antiretroviral Therapy in Obese SIVInfected Rhesus Macaques

Obesity (Silver Spring, Md.), 2022-11, Vol.30, p.186-187

2022

Volltextzugriff (PDF)

S1335 Tenofovir Disoproxil Fumarate Switching to Tenofovir Alafenamide for Three Years Resulted in Improvement of Hepatic Fibrosis by APRI and FIB-4 Score as Well as Shear Wave Elastography in Patients With Chronic Hepatitis B

The American journal of gastroenterology, 2022-10, Vol.117 (10S), p.e961-e961

2022

Volltextzugriff (PDF)

Effects of HIV and Antiretroviral Therapy on Resting Metabolic Rate Among Postpartum Women

Obesity (Silver Spring, Md.), 2022-11, Vol.30, p.223-224

2022

Volltextzugriff (PDF)

T‐cell exhaustion in HIV infection

Immunological reviews, 2019-11, Vol.292 (1), p.149-163

2019

Volltextzugriff (PDF)

S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S530-S530

2021

Volltextzugriff (PDF)

S1146 Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Virus Infection in the African American Community

The American journal of gastroenterology, 2021-10, Vol.116 (1), p.S537-S538

2021

Volltextzugriff (PDF)

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment

Journal of the International AIDS Society, 2020-04, Vol.23 (4), p.e25489-n/a

2020

Volltextzugriff (PDF)

Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the western cape, South Africa

Journal of medical virology, 2011-10, Vol.83 (10), p.1764-1769

2011

Volltextzugriff (PDF)

Does Switching to Tenofovir Alafenamide (TAF) Avoid Organ Toxicity Associated with Other Anti-Hepatitis B Virus (HBV) Medications in Chronic HBV+ Patients?: 1016

The American journal of gastroenterology, 2018-10, Vol.113 (Supplement), p.S571-S572

2018

Volltextzugriff (PDF)

HIV/SARS‐CoV‐2 coinfection: A global perspective

Journal of medical virology, 2021-02, Vol.93 (2), p.726-732

2021

Volltextzugriff (PDF)

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

HIV medicine, 2021-05, Vol.22 (5), p.372-378

2021

Volltextzugriff (PDF)

Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals

Cochrane database of systematic reviews, 2010-10 (10), p.CD008740

2010

Volltextzugriff (PDF)

Two‐drug vs. three‐drug combinations for HIV‐1: Do we have enough data to make the switch?

HIV medicine, 2019-04, Vol.20 (S4), p.2-12

2019

Volltextzugriff (PDF)

COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain

American journal of transplantation, 2020-07, Vol.20 (7), p.1849-1858

2020

Volltextzugriff (PDF)

1 – 25 von 4.088

Suche als RSS-Feed

Aktive Filter

ThemaAids

KollektionWiley Online Library Journals

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(4.021)
Mit Volltextzugriff
(3.958)

Publikationsform

Sprache

Englisch
(4.084)
Japanisch
(240)
Deutsch
(16)
Französisch
(5)
Chinesisch
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(3.511)
Life Sciences & Biomedicine
(3.461)
Humans
(3.186)
Hiv Infections - Drug Therapy
(2.282)
Human Immunodeficiency Virus
(2.203)
Hiv
(2.120)
Female
(2.016)
Male
(1.934)
Adult
(1.810)
Antiretroviral Drugs
(1.750)
Infectious Diseases
(1.557)
Middle Aged
(1.297)
Antiretroviral Therapy
(1.207)
Antiretroviral Therapy, Highly Active
(989)
Anti-Hiv Agents - Therapeutic Use
(779)
Antiretroviral Agents
(724)
Viral Load
(689)
Biological And Medical Sciences
(682)
Medical Sciences
(656)
Hiv Infections - Complications
(644)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(23)

Menü

Weitere Dienste

Einstellungen

Mobile phone text messaging for promoting adherence to antiretroviral therapy in patients with HIV infection

Efavirenz or nevirapine in three-drug combination therapy with two nucleoside or nucleotide-reverse transcriptase inhibitors for initial treatment of HIV infection in antiretroviral-naïve individuals

Long‐acting injectable cabotegravir for PrEP: A game‐changer in HIV prevention?

HBV, HCV, and HBV/HCV co‐infection among HIV‐positive patients in Hunan province, China: Regimen selection, hepatotoxicity, and antiretroviral therapy outcome

Abnormal laboratory findings and plasma concentration monitoring of lopinavir and ritonavir in COVID‐19

Antiretroviral therapy (ART) for treating HIV infection in ART-eligible pregnant women

Interventions to improve adherence to antiretroviral therapy in children with HIV infection

InterPrEP: internet‐based pre‐exposure prophylaxis with generic tenofovir disoproxil fumarate/emtrictabine in London – analysis of pharmacokinetics, safety and outcomes

Optimal time for initiating antiretroviral therapy (ART) in HIV-infected, treatment-naive children aged 2 to 5 years old

Life expectancy of HIV‐positive people after starting combination antiretroviral therapy: a meta‐analysis

Humanized PA14 (a monoclonal CCR5 antibody) for treatment of people with HIV infection

The Response to Antiretroviral Therapy in Obese SIVInfected Rhesus Macaques

S1335 Tenofovir Disoproxil Fumarate Switching to Tenofovir Alafenamide for Three Years Resulted in Improvement of Hepatic Fibrosis by APRI and FIB-4 Score as Well as Shear Wave Elastography in Patients With Chronic Hepatitis B

Effects of HIV and Antiretroviral Therapy on Resting Metabolic Rate Among Postpartum Women

T‐cell exhaustion in HIV infection

S1127 Safety and Efficacy of Switching to Tenofovir Alafenamide (TAF) in Virally Suppressed Chronic Hepatitis B (CHB) Patients With Renal Impairment: Week 48 Results From a Phase 2 Open-Label Study

S1146 Tenofovir Alafenamide vs Tenofovir Disoproxil Fumarate for the Treatment of Chronic Hepatitis B Virus Infection in the African American Community

Systematic review of the efficacy and safety of antiretroviral drugs against SARS, MERS or COVID‐19: initial assessment

Antiretroviral resistance patterns and factors associated with resistance in adult patients failing NNRTI-based regimens in the western cape, South Africa

Does Switching to Tenofovir Alafenamide (TAF) Avoid Organ Toxicity Associated with Other Anti-Hepatitis B Virus (HBV) Medications in Chronic HBV+ Patients?: 1016

HIV/SARS‐CoV‐2 coinfection: A global perspective

Immune deficiency is a risk factor for severe COVID‐19 in people living with HIV

Tenofovir or zidovudine in three-drug combination therapy with one nucleoside reverse transcriptase inhibitor and one non-nucleoside reverse transcriptase inhibitor for initial treatment of HIV infection in antiretroviral-naïve individuals

Two‐drug vs. three‐drug combinations for HIV‐1: Do we have enough data to make the switch?

COVID‐19 in solid organ transplant recipients: A single‐center case series from Spain

Aktive Filter

Suchergebnisse filtern